156 related articles for article (PubMed ID: 6764670)
21. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases.
Todd HD; Coffee MS; Waalkes TP; Abeloff MD; Parsons RG
J Natl Cancer Inst; 1980 Nov; 65(5):901-4. PubMed ID: 6253707
[TBL] [Abstract][Full Text] [Related]
23. [Variations in fibronectin plasma levels after surgical stress].
Oliva A; Mancuso A; Pizzo A; Ardita F
Minerva Ginecol; 1995 Dec; 47(12):535-8. PubMed ID: 8720975
[TBL] [Abstract][Full Text] [Related]
24. Cellular fibronectin in patients with transitional cell carcinoma of the bladder.
Hegele A; Heidenreich A; Varga Z; von Knobloch R; Olbert P; Kropf J; Hofmann R
Urol Res; 2003 Feb; 30(6):363-6. PubMed ID: 12599015
[TBL] [Abstract][Full Text] [Related]
25. Determination of plasma fibronectin and serum C-reactive protein in patients with cerebrovascular events.
Pençe S; Yilmaz G; Yilmaz N; Kocoglu H; Namiduru E; Yüncü M; Gökalp N
Int J Clin Pract; 2003 Mar; 57(2):91-5. PubMed ID: 12661789
[TBL] [Abstract][Full Text] [Related]
26. [Dynamics of the plasma fibronectin level in patients with food poisoning].
Pak SG; Bogin IB; Kakhnovskaia NL; Sokurenko EV; Berchenko VV
Ter Arkh; 1988; 60(11):71-5. PubMed ID: 3238583
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of plasma fibronectin concentrations in normal pregnancy and pregnancy induced hypertension and its clinical significance].
Yao ZW; Mao YL; Chen JZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):521-3, 572. PubMed ID: 7835126
[TBL] [Abstract][Full Text] [Related]
28. Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias.
Ozatli D; Koçoğlu H; Haznedaroğlu IC; Koşar A; Büyükaşik Y; Ozcebe O; Kirazli S; Dündar SV
Haematologia (Budap); 1999; 29(4):277-83. PubMed ID: 10438067
[TBL] [Abstract][Full Text] [Related]
29. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
30. [Importance of plasma fibronectin in vascular diseases of diabetic patients].
Borrego Galán JC; de Portugal Alvarez J; Sánchez Rodríguez A; Chimpen Ruiz V; Martín Oterino JA; Gutiérrez San Pedro N
An Med Interna; 1991 Mar; 8(3):111-5. PubMed ID: 1893015
[TBL] [Abstract][Full Text] [Related]
31. [Plasma fibronectin level in patients with depression of hematopoiesis].
Vasil'ev SA; Savchenko VG; Margulis EIa; Ermolin GA; Kotelianskiĭ VE
Ter Arkh; 1985; 57(7):119-24. PubMed ID: 4049264
[TBL] [Abstract][Full Text] [Related]
32. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Zhao HW; Lu CJ; Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776
[TBL] [Abstract][Full Text] [Related]
33. [The content of fibronectin in the blood of patients with psoriasis].
Vasil'eva NIu; Nazimova SV; Tatarinov IuS
Lab Delo; 1991; (3):27-8. PubMed ID: 1710713
[TBL] [Abstract][Full Text] [Related]
34. Fibronectin levels in normal subjects and patients admitted to a respiratory intensive care unit.
Purves LR; Brown G; Linton N
S Afr Med J; 1982 May; 61(20):733-6. PubMed ID: 7079880
[TBL] [Abstract][Full Text] [Related]
35. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
[TBL] [Abstract][Full Text] [Related]
36. [Plasma fibronectin in gastric and duodenal ulcer].
Levitan BN; Perova NIu; Astakhin AV; Trubnikov GA
Klin Med (Mosk); 1999; 77(9):31-3. PubMed ID: 10599222
[TBL] [Abstract][Full Text] [Related]
37. [Determination of plasma fibronectin in myeloproliferative and lymphoproliferative diseases and other malignancies].
Kalabay L; Cseh K; Jakab L; Török J; Pozsonyi T; Marticsek J; Benedek S
Immun Infekt; 1986 Feb; 14(1):13-7. PubMed ID: 3082743
[TBL] [Abstract][Full Text] [Related]
38. Plasma fibronectin concentration in patients with chronic renal failure and treated with haemodialysis.
Eriksen HO; Tranebjaerg L; Clemmensen I; Kjersem H; Skjoldby O
Scand J Clin Lab Invest; 1983 Dec; 43(8):723-6. PubMed ID: 6665521
[TBL] [Abstract][Full Text] [Related]
39. Effect of blood transfusion on in vivo levels of plasma fibronectin.
Snyder EL; Mosher DF; Hezzey A; Golenwsky G
J Lab Clin Med; 1981 Sep; 98(3):336-41. PubMed ID: 7264434
[TBL] [Abstract][Full Text] [Related]
40. Plasma fibronectin as a marker of sepsis.
Ruiz Martín G; Prieto Prieto J; Veiga de Cabo J; Gomez Lus L; Barberán J; González Landa JM; Fernández C
Int J Infect Dis; 2004 Jul; 8(4):236-43. PubMed ID: 15234328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
